In this video, Harry Erba, MD, PhD, professor of medicine, director of the University of Alabama at Birmingham Hematologic Malignancy Program, and associate director for clinical research at the University of Alabama at Birmingham Comprehensive Cancer Center, discusses the importance of oncology continuing medical education (CME). Dr. Erba says “We have a challenge. . . science is moving quickly, new drugs are being developed, and clinicians have to learn how to use these drugs.” CME through Physicians’ Education Resource®, LLC (PER®), is a perfect way to provide education to clinicians in real-time. Dr. Erba believes that CME allows for the diffusion of important information as quick as possible, allowing practitioners to implement advances to their next patient. Oncology CME is providing invaluable information on a day-to-day basis to keep oncologists on the cutting-edge of scientific advancement. Learning from the experts provides oncologists with information that simply cannot be found on a drug label.